TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+5.91%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$497M
AUM Growth
+$497M
(+3.2%)
Cap. Flow
+$46.2M
Cap. Flow
% of AUM
9.3%
Top 10 Holdings %
Top 10 Hldgs %
77%
Holding
31
New
11
Increased
2
Reduced
5
Closed
2
Top Buys
| 1 |
ANI Pharmaceuticals
ANIP
|
$13.8M |
| 2 |
ALLK
Allakos
ALLK
|
$13M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$11.1M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$9.66M |
| 5 |
Legend Biotech
LEGN
|
$9.32M |
Top Sells
| 1 |
Aptevo Therapeutics
APVO
|
$27.2M |
| 2 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$3.71M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$2.05M |
| 4 |
NextCure
NXTC
|
$2.02M |
| 5 |
Corvus Pharmaceuticals
CRVS
|
$1.56M |
Sector Composition
| 1 | Healthcare | 95.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASLN
26
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.3M | 0.46% |
2,054,925
+1,079,620
| +111% | +$1.21M |
|
27
Equillium
EQ
$62.2M
| $2.26M | 0.45% |
600,000
| – | – |
|
28
Relmada Therapeutics
RLMD
$37.2M
| $1.33M | 0.27% |
59,122
-40,878
| -41% | -$921K |
|
29
CytomX Therapeutics
CTMX
$336M
| $660K | 0.13% |
+152,345
| New | +$660K |
|
|
30
Aptevo Therapeutics
APVO
$5.39M
| – | – |
-1,760,000
| Closed | -$27.2M |
|
|
31
NextCure
NXTC
$13.5M
| – | – |
-300,000
| Closed | -$2.02M |
|